Screener
LeMaitre Vascular LMAT Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by LeMaitre Vascular in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333762
| Line item | For the six months ended / June 30, 2026 | For the six months ended / June 30, 2025 |
|---|---|---|
| Prepaid expenses and other assets | (1,363) | 1,676 |
| Accounts payable and other liabilities | (6,475) | (1,250) |
| Accrued interest | — | 2,156 |
| Net cash provided by operating activities | 31,058 | 29,330 |
| Investing activities | ||
| Purchases of short-term marketable securities | (231,434) | (17,849) |
| Purchases of property and equipment | (5,096) | (2,725) |
| Payments related to acquisitions, net of cash acquired | (158) | (95) |
Item 1. Financial Statements
FAQ
- What is LeMaitre Vascular's operating cash flow?
- LeMaitre Vascular (LMAT) reported operating cash flow of $15.97M in Q2 2026.
- How has LeMaitre Vascular's operating cash flow changed year-over-year?
- LeMaitre Vascular's operating cash flow decreased by 21.3% year-over-year, from $20.29M to $15.97M.
- What is the long-term trend for LeMaitre Vascular's operating cash flow?
- Over 3 years (2022 to 2025), LeMaitre Vascular's operating cash flow has grown at a 47.4% compound annual growth rate (CAGR), from $25.38M to $81.25M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about LeMaitre Vascular's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude